Alternatived Products of [ 1246525-60-9 ]
Product Details of [ 1246525-60-9 ]
CAS No. : | 1246525-60-9 |
MDL No. : | |
Formula : |
C17H10F9NO2
|
Boiling Point : |
- |
Linear Structure Formula : | - |
InChI Key : | DUXWIYXHHGNUJU-UHFFFAOYSA-N |
M.W : |
431.25
|
Pubchem ID : | 17980288 |
Synonyms : |
|
Chemical Name : | N-(4-(1,1,1,3,3,3-Hexafluoro-2-hydroxypropan-2-yl)phenyl)-4-(trifluoromethyl)benzamide |
Calculated chemistry of [ 1246525-60-9 ] Expand+
Physicochemical Properties
Num. heavy atoms : |
29 |
Num. arom. heavy atoms : |
12 |
Fraction Csp3 : |
0.24 |
Num. rotatable bonds : |
7 |
Num. H-bond acceptors : |
11.0 |
Num. H-bond donors : |
2.0 |
Molar Refractivity : |
81.67 |
TPSA : |
49.33 ?2 |
Pharmacokinetics
GI absorption : |
Low |
BBB permeant : |
No |
P-gp substrate : |
No |
CYP1A2 inhibitor : |
No |
CYP2C19 inhibitor : |
Yes |
CYP2C9 inhibitor : |
Yes |
CYP2D6 inhibitor : |
Yes |
CYP3A4 inhibitor : |
No |
Log Kp (skin permeation) : |
-5.49 cm/s |
Lipophilicity
Log Po/w (iLOGP) : |
2.57 |
Log Po/w (XLOGP3) : |
4.84 |
Log Po/w (WLOGP) : |
8.64 |
Log Po/w (MLOGP) : |
4.44 |
Log Po/w (SILICOS-IT) : |
5.17 |
Consensus Log Po/w : |
5.13 |
Druglikeness
Lipinski : |
1.0 |
Ghose : |
None |
Veber : |
0.0 |
Egan : |
1.0 |
Muegge : |
1.0 |
Bioavailability Score : |
0.55 |
Water Solubility
Log S (ESOL) : |
-5.41 |
Solubility : |
0.00169 mg/ml ; 0.00000392 mol/l |
Class : |
Moderately soluble |
Log S (Ali) : |
-5.61 |
Solubility : |
0.00106 mg/ml ; 0.00000246 mol/l |
Class : |
Moderately soluble |
Log S (SILICOS-IT) : |
-6.94 |
Solubility : |
0.0000494 mg/ml ; 0.000000115 mol/l |
Class : |
Poorly soluble |
Medicinal Chemistry
PAINS : |
0.0 alert |
Brenk : |
0.0 alert |
Leadlikeness : |
2.0 |
Synthetic accessibility : |
1.91 |
Safety of [ 1246525-60-9 ]
Signal Word: | Warning |
Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 |
UN#: | N/A |
Hazard Statements: | H302 |
Packing Group: | N/A |
GHS Pictogram: |
|